Collectively, these results suggest that no described individual polymorphic HML-2 provirus is associated with breast cancer occurrence for the CPS-II genomic samples screened; however these results do not exclude the possible association of HML-2 occurrence within a subset of breast cancer cases, or other disease types with implication for involvement. This evidence concerns the gene CLEC10A and breast carcinoma.